Psilocybin Therapy and Mushroom Wisdom | Francoise Bourzat and Dr. Rosalind Watts ~ ATTMind 127

Each a leader in the field of psilocybin therapy and medicine, Francoise Bourzat and Rosalind Watts are on the show to talk with each other about psilocybin for depression, trauma, dying; as well as integration, the role of community in getting the most out of our psychedelic experiences, why the depression comes back after psilocybin therapy, and the challenges of being a woman in psychedelic research. We also discuss the ethics of screening people for therapy, using mushrooms in naturalistic settings, ego inflation, and the impact of venture capitalism is having on psychedelic culture.   --LINKS-- For links to Jeronimo's work, full show notes, and to watch this episode in video, head to https://bit.ly/ATTMind127 ***Full Topics Breakdown Below***   --- SUPPORT THIS PODCAST — ► Patreon: https://patreon.com/jameswjesso ► Donations: https://www.paypal.me/JWJesso ► Merchandise: https://www.jameswjesso.com/shop/ ► More options: https://www.jameswjesso.com/support/ This episode's Sponsor: https://www.jameswjesso.com/coffee Use promo code JESSO to get 10% off your order and give 5% to psychedelic research. ► Newsletter: https://www.jameswjesso.com/newsletter   *** Extra BIG thanks to my patrons on Patreon for helping keep this podcast alive! Especially, Andreas D, Clea S, Joe A, Ian C, David WB, Yvette FC, Ann-Madeleine, Dima B, Talpitoo, & Chuck W ************** Episode Breakdown The basis of why these two women have come together for this episode Francoise's upcoming Research on psilocybin and grief Navigating the Challenges of being a woman in psychedelic research, and science in general Team support structures for handing difficult psilocybin therapy sessions as a facilitator Preparing a team to research psilocybin therapy and processing grief The masculine striving and the feminine building of community and family The role of grief and grieving in the process of healing with psilocybin Encounter with eternity help us reconsolidate the dying process The integration processes used during the psilocybin for depression trials How long should we wait between psilocybin journeys? A point about the value of heart rate variability as something o measure during psilocybin research Discussing why (and how) the depression comes back after psilocybin Psilocybin therapy and trauma healing Comparing MDMA to psilocybin insofar as trauma healing Concerns around how fast psychedelics are being mainstreamed The ethics of screening people for psilocybin therapy The role of community in getting the most benefit from psilocybin Building that community using the 'pollinator model' Discussions on the psilocybin service initiative in Oregon Using mushrooms in natural settings Discussions about psychedelic medicine in the context of capitalism Psychedelic ego inflation and narcissism increased by psychedelic use Why profitable psychedelic therapy will likely be poor therapy Quality psilocybin therapy vs 'kfc' therapy How big business legislation may hurt good people to keep doing their work in the context of legalization   ************** --- SUPPORT THIS PODCAST — ► Patreon: https://patreon.com/jameswjesso ► Donations: https://www.paypal.me/JWJesso ► Merchandise: https://www.jameswjesso.com/shop/ ► More options: https://www.jameswjesso.com/support/   This episode's Sponsor: https://www.jameswjesso.com/coffee Use promo code JESSO to get 10% off your order and give 5% to psychedelic research.   ► Newsletter: https://www.jameswjesso.com/newsletter --- BOOKS — Decomposing The Shadow: https://www.jameswjesso.com/decomposing-the-shadow/ The True Light Of Darkness: https://www.jameswjesso.com/true-light-darkness/   --- LINKS — Website: https://www.jameswjesso.com/ Speaking Tour: https://www.jameswjesso.com/events/ Podcast: https://www.jameswjesso.com/podcast/ Twitter: https://twitter.com/jameswjesso Instagram: https://www.instagram.com/attmindpodcast/ Facebook: https://www.facebook.com/jameswjesso

There are no comments yet.

Please log in to write the first comment.